NEW YORK (Reuters Health) – Rates of major adverse cardiovascular events (MACEs) are lower in hypertensive patients with coronary artery disease on amlodipine when candesartan is added to…
NEW YORK (Reuters Health) – For patients with diabetes and hypertension, an antihypertensive regimen combining an ACE inhibitor with a calcium channel blocker provides better protection against cardiovascular…
NEW YORK (Reuters Health) – Even though carotid intima media thickness (cIMT) independently predicts cardiovascular disease events, this parameter does not add useful information to traditional risk factor…
NEW YORK (Reuters Health) – Performing percutaneous coronary interventions (PCI) in non-infarct-related coronary vessels along with primary PCI for ST-segment elevation myocardial infarction (STEMI) appears to jeopardize patient…
NEW YORK (Reuters Health) – Despite its widespread use, there is no conclusive evidence that oxygen therapy benefits patients with acute myocardial infarction (AMI), according to a paper…
NEW YORK (Reuters Health) – The new-generation zotarolimus-eluting coronary stent was as safe and effective after 13 months’ follow-up as the everolimus-eluting stent in a study with minimal…
NEW YORK (Reuters Health) – The novel antiarrhythmic agent vernakalant is a safe and effective agent for pharmacologic conversion of recent-onset atrial fibrillation (AF) in hemodynamically stable patients,…
NEW YORK (Reuters Health) – Balloon angioplasty, drug-eluting stents, and bare metal stents appear to be equally effective at reducing death or myocardial infarction (MI) over a year’s…
NEW YORK (Reuters Health) – Children receiving the bisphosphonate pamidronate for severe bone demineralization have a prolonged corrected QT interval (QTc), French researchers report online May 25th in…
NEW YORK (Reuters Health) – Preprocedural use of glycoprotein IIb/IIIa inhibitors (GPIs) in primary percutaneous coronary intervention (PCI) after acute myocardial infarction may improve clinical outcomes, according to…